Live Breaking News & Updates on Receive Additional Near Term

KemPharm Confirms Receipt of $10 Million Milestone Payment for FDA Approval of AZSTARYS™ Per License Agreement with Affiliate of Gurnet Point Capital
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Perry Sternberg , Travisc Mickle , Us Drug Enforcement Administration , Corium Inc , Drug Administration , Shire Plc , Exchange Commission , Head Of The Neuroscience Division , Securities Exchange , Kempharm Inc , Takeda Pharmaceutical Corporation , Wall Street , Receive Additional Near Term , Milestone Payment Following , Commave Therapeutics , Gurnet Point Capital , License Agreement , Chief Commercial , Neuroscience Division , Takeda Pharmaceutical Corporation Limited , Enforcement Administration , Ligand Activated Therapy , Concerning Forward Looking Statements , Securities Act , Securities Exchange Act , Annual Report ,